Celularity CMO Adrian Kilcoyne resigns effective August 6, 2024

Celularity Inc

Adrian Kilcoyne, EVP and Chief Medical Officer, resigns to pursue other opportunities.
Resignation effective August 6, 2024; no successor announced.
No disagreement with Celularity cited; departure unrelated to operations or policies.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Adrian Kilcoyne

Executive Vice President and Chief Medical Officer

CELU · Celularity Inc

Effective: 2024-08-06
Filed: September 13, 2024, 7:59 PM ET

Adrian Kilcoyne, M.D., M.P.H., M.B.A. of Celularity Inc., or Celularity, provided notice of resignation from his role as Executive Vice President and Chief Medical Officer, effective as of August 6, 2024, to pursue other opportunities.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Adrian Kilcoyne resigned as Executive Vice President and Chief Medical Officer at Celularity Inc.

Action: resigned
Role: Executive Vice President and Chief Medical Officer

Exact text from the filing

Adrian Kilcoyne, M.D., M.P.H., M.B.A. of Celularity Inc., or Celularity, provided notice of resignation from his role as Executive Vice President and Chief Medical Officer, effective as of August 6, 2024, to pursue other opportunities.

View on SEC.gov

Celularity Inc filing history →

Source: SEC EDGAR

accession 0001493152-24-036234

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.